Nifty
Sensex
:
:
9039.25
30672.59
-67.00 (-0.74%)
-260.31 (-0.84%)

Pharmaceuticals & Drugs - Domestic

Rating :
90/99

BSE: 506820 | NSE: ASTRAZEN

3137.45
22-May-2020
  • Open
  • High
  • Low
  • Previous Close
  •  3080.00
  •  3195.00
  •  3050.00
  •  3028.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  151730
  •  4738.08
  •  3375.00
  •  1632.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,844.38
  • 108.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,671.07
  • N/A
  • 21.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 2.66%
  • 16.75%
  • FII
  • DII
  • Others
  • 1.22%
  • 3.49%
  • 0.88%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 7.09
  • 10.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.06

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 39.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 78.87
  • 104.91
  • 102.54

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.63
  • 18.63
  • 18.63

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 42.22
  • 65.66
  • 55.31

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma gets permission from DCGI for Acalabrutinib Capsules
    13th Mar 2020, 09:06 AM

    Acalabrutinib 100 mg capsules is indicated for treatment of patients with chronic lymphocytic leukaemia/ small lymphocytic lymphoma

    Read More
  • AstraZeneca Pharma launches QTERN tablets in India
    24th Feb 2020, 12:51 PM

    QTERN is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.